Domov › Rakovina pľúc › Georgia

Klinické štúdie Rakovina pľúc v štáte Georgia

40 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v štáte Georgia.

Mestá v štáte Georgia

Oficiálny text štúdie (anglicky)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Northside Hospital, Atlanta
Northside Hospital - Duluth, Duluth
Northeast Georgia Medical Center-Gainesville, Gainesville
a 2 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Northeast Georgia Medical Center Braselton, Braselton
Atlanta VA Medical Center, Decatur
Northeast Georgia Medical Center-Gainesville, Gainesville
a 4 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

CTCA at Southeastern Regional Medical Center, Newnan

Prebieha náborFáza 3

Vek 70 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta
a 2 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Winship Cancer Institute of Emory University, Atlanta

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

University Cancer and Blood Center, Athens
Piedmont Healthcare, Inc, Atlanta
Winship Cancer Institute, Atlanta

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06881784

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Piedmont Atlanta Hospital ( Site 4000), Atlanta
Emory University School of Medicine-Phase I ( Site 0056), Atlanta
Northside Hospital ( Site 0055), Atlanta
a 3 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06312137

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

University Cancer & Blood Center, LLC, Athens

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07489066

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Northwest Georgia Oncology Centers, P.C., Marietta

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06712316

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Piedmont Healthcare, Atlanta
John B Amos Cancer Center, Columbus

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07100080

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

Emory at Avalon - Primary Care, Alpharetta
Emory Clinic at Old Fourth Ward, Atlanta
Emory Clinic at Midtown, Atlanta
a 41 ďalších

Prebieha nábor

Vek 50 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07711691

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06287775

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Georgia Cancer Center at Augusta University, Augusta

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06293898

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Piedmont Cancer Institute, PC, Atlanta
City of Hope® Atlanta, Newnan
Summit Cancer Care PC, Savannah

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University Cancer & Blood Center, LLC, Athens
Emory University School of Medicine- Grady Campus, Atlanta
Winship Cancer Institute, Emory University, Atlanta

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06119581

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Emory University, Atlanta

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT06400472

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Atlanta

Prebieha náborFáza 1/2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07038343

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Northside Hospital Atlanta, Atlanta

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06712355

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Emory University - Winship Cancer Institute, Atlanta

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT06582017

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Grady Health System, Atlanta
Emory Proton Therapy Center, Atlanta
Emory University Hospital Midtown, Atlanta
a 8 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05624996

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Atlanta

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Winship Cancer Institute - Emory University, Atlanta

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT04198766

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

University Cancer and Blood Center LLC, Athens
Northside Hospital, Atlanta
Northside Hospital - Duluth, Duluth
a 3 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT05642572

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

University Cancer and Blood Center, Athens

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 27. 5. 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Piedmont Healthcare, Atlanta

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 5. 2026 · NCT05379985

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

University Cancer and Blood Center LLC, Athens
Northeast Georgia Medical Center-Gainesville, Gainesville

Prebieha náborFáza 2

18 Minutes · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Grady Health System, Atlanta
Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
a 8 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT06616584

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

University Cancer & Blood Center, Athens

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT05168566

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

City of Hope Atlanta Cancer Center, Newnan

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT07288034

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 4. 2026 · NCT06495125

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Emory University Hospital/Winship Cancer Institute, Atlanta

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 3. 2026 · NCT04762199

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

City of Hope at Georgia - Atlanta, Newnan

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 3. 2026 · NCT06196008

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Emory University/Winship Cancer Institute, Atlanta

Prebieha náborSkorá fáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 2. 2026 · NCT05493566

Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 2. 2026 · NCT06731270

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

North Georgia Health System, Gainesville

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT05366881

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Northside Hospital, Atlanta
Northeast Georgia Medical Center Braselton, Braselton
John B Amos Cancer Center, Columbus
a 8 ďalších

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 1. 2026 · NCT06073431

Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer

Emory University Hospital Midtown, Atlanta
Emory University, Atlanta
Emory Saint Joseph's Hospital, Atlanta

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 10. 2025 · NCT05244239

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Atlanta
Massive Bio SYNERGY-AI site, Savannah

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

SpeciCare, Inc, Gainesville

Prebieha náborObservačná štúdia

Vek 50 a viac · Všetky pohlavia · Aktualizované 5. 8. 2025 · NCT06122077

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.